Skip to content

Effect of Goal-directed Fluid Therapy on Postoperative Outcomes in Meningloma Resection with Intraoperative Mannitol Application

Effect of Goal-directed Fluid Therapy on Postoperative Outcomes in Meningloma Resection with Intraoperative Mannitol Application

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009007
Enrollment
Unknown
Registered
2016-08-10
Start date
2016-10-01
Completion date
Unknown
Last updated
2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meningloma

Interventions

Group E:Goal-directed Fluid Therapy
Group C:Standard care

Sponsors

Xuan Wu hospital of CCMU
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Elective 1st time meningloma resection; 2. Aged more than 18 years old; 3. American Society of Anesthesiologists (ASA)Physical status I-III.;Inclusion criteria: 1. Elective 1st time meningloma resection; 2. Aged more than 18 years old; 3. American Society of Anesthesiologists (ASA)Physical status I-III.

Exclusion criteria

Exclusion criteria: 1. Patient refusal; 2. Require ICU admission before surgery; 3. Urgent or emergent surgery; 4. Patients dont use mannitol or use overdose(>2g/kg) mannitol.;Exclusion criteria: 1. Patient refusal; 2. Require ICU admission before surgery; 3. Urgent or emergent surgery; 4. Patients dont use mannitol or use overdose(>2g/kg) mannitol.

Design outcomes

Primary

MeasureTime frame
Postoperative complication rate;;Postoperative complication rate;

Secondary

MeasureTime frame
GI recovery (d);ICU stay;Hospital stay;Use of vasopressors;Lactate;ALB;ALT;AST;Hb;sCr;BUN;CO;Muscle regional oxygen saturation;Hospitalization expenses;Platelet;;GI recovery (d);ICU stay;Hospital stay;Use of vasopressors;Lactate;ALB;ALT;AST;Hb;sCr;BUN;CO;Muscle regional oxygen saturation;Hospitalization expenses;Platelet;

Countries

China

Contacts

Public ContactWANG TIANLONG;WANG TIANLONG ;

Xuanwu Hospital of CCMU;Xuanwu Hospital of CCMU

w_tl5595@hotmail.com;w_tl5595@hotmail.com+86 13910525304;+86 13910525304

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026